CKK Retail Mart IPO...
23 Jan, 2026
Rodec Pharma IPO
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Rodec Pharma IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Rodec Pharma IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹10 per Equity Share |
| Issue Price Band | - |
| Lot Size | - |
| Sale Type | Offer for Sale (OFS) |
| Total Issue Size | Up to 5,650,000 Equity Shares (Aggregating up to [●] Cr) |
| Reserved for Market Maker | - |
| Fresh Issue(Ex Market Maker) | Not Applicable |
| Offer for Sale | Up to 5,650,000 Equity Shares (Aggregating up to [●] Cr) |
| Net Offered to Public | - |
| Issue Type | 100% Book Built Offer |
| Listing At | BSE and NSE |
| Share Holding Pre Issue | 2,25,84,800 shares |
| Share Holding Post Issue | 2,25,84,800 shares |
Rodec Pharma IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | - |
| IPO Close Date | - |
| Tentative Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Tentative Listing Date | - |
| Cut-off time for UPI mandate confirmation | 5:00 PM on the Bid/Offer Closing Date |
Rodec Pharma IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | - | ~₹14,000 - ₹15,000 |
| Individual investors (Retail) (Max) | 13-14 | - | Up to ₹2,00,000 |
| S-HNI (Min) | 14-15 | - | Over ₹2,00,000 |
| S-HNI (Max) | 66-70 | - | Up to ₹10,00,000 |
| B-HNI (Min) | 71+ | - | Over ₹10,00,000 |
Rodec Pharma IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Promoter Holding Pre Issue | 92.40% |
| Promoter Holding Post Issue | - |
Competitive Strength:
- • Integrated manufacturing and nationwide distribution network for veterinary drugs and supplements
- • Broad product portfolio spanning antibiotics, hormones, vitamins and feed nutrition.
- • Strategic partnerships expanding into poultry and high‑growth animal health segments.
Rodec Pharma IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept 30, 2025 | 78.07 | 63.71 | 9.73 | 59.96 | 37.37 | 1.40 | ||||||||||||||||||||||||||||||||||
| Fiscal 2025 | 71.99 | 108.19 | 18.26 | 50.04 | 49.93 | 8.25 | ||||||||||||||||||||||||||||||||||
| Fiscal 2024 | 50.62 | 89.61 | 11.04 | 31.75 | 31.65 | 6.70 | ||||||||||||||||||||||||||||||||||
| Fiscal 2023 | 44.13 | 71.72 | 5.21 | 20.67 | 20.56 | 11.72 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 36.49% |
| ROCE | 40.94% |
| Debt/Equity | 0.17 |
| RoNW | 36.49% |
| PAT Margin | 17.16% |
| EBITDA Margin | 24.21% |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 8.08 | |
| P/E (x) |
IPO DRHP Status
| # | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 11-01-2026 | View DRHP |
| 2 | SEBI/Exchange approval received | - | - |
Read more :
.jpg)
